ELV
Elevance Health
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ELV
- PE Ratio
The PE ratio for Elevance Health stock stands at 17.58 as of Jun 5, 2026. This is calculated based on the current EPS of $23.64 and the stock price of $415.53 per share. An increase of 26% has been seen in the P/E ratio compared to the average of 14.0 of the last 4 quarters.
ELV PE ratio history
Over the last ten years, the average PE ratio of Elevance Health has been 16.49. The current 17.58 PE ratio is 7% above the historical average. Over the past ten years, ELV's PE ratio was at its highest in the Jun 2021 quarter at 22.09, with a price of $381.8 and an EPS of $17.28. The Jun 2020 quarter recorded the bottom point at 11.24, with a price of $262.98 and an EPS of $23.39.
Elevance Health PE ratio by year
Maximum annual increase: 50.14% in 2013
Maximum annual decrease: -23.09% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 13.87 | -2.94% | $350.55 | $25.28 |
| 2024 | 14.29 | -23.09% | $368.9 | $25.81 |
| 2023 | 18.58 | -11.06% | $471.56 | $25.38 |
| 2022 | 20.89 | 13.84% | $512.97 | $24.56 |
| 2021 | 18.35 | 4.2% | $463.54 | $25.26 |
| 2020 | 17.61 | 9.65% | $321.09 | $18.23 |
| 2019 | 16.06 | -11.17% | $302.03 | $18.81 |
| 2018 | 18.08 | 18.09% | $262.63 | $14.53 |
| 2017 | 15.31 | 0% | $225.01 | $14.7 |
| 2016 | 15.31 | 6.84% | $143.77 | $9.39 |
| 2015 | 14.33 | 6.15% | $139.44 | $9.73 |
| 2014 | 13.5 | 21.84% | $125.67 | $9.31 |
| 2013 | 11.08 | 50.14% | $92.39 | $8.34 |
| 2012 | 7.38 | -18.09% | $60.92 | $8.26 |
| 2011 | 9.01 | 11.37% | $66.25 | $7.35 |
Elevance Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 12.38 | -10.74% | $292.75 | $23.64 |
| Dec 2025 | 13.87 | 5.48% | $350.55 | $25.28 |
| Sep 2025 | 13.15 | -20.11% | $323.12 | $24.57 |
| Jun 2025 | 16.46 | -2.37% | $388.96 | $23.63 |
| Mar 2025 | 16.86 | 17.98% | $434.96 | $25.8 |
| Dec 2024 | 14.29 | -24.11% | $368.9 | $25.81 |
| Sep 2024 | 18.83 | -0.21% | $520 | $27.62 |
| Jun 2024 | 18.87 | -3.03% | $541.86 | $28.72 |
| Mar 2024 | 19.46 | 4.74% | $518.54 | $26.64 |
| Dec 2023 | 18.58 | 8.09% | $471.56 | $25.38 |
| Sep 2023 | 17.19 | 2.69% | $435.42 | $25.33 |
| Jun 2023 | 16.74 | -7.1% | $444.29 | $26.54 |
| Mar 2023 | 18.02 | -13.74% | $459.81 | $25.51 |
| Dec 2022 | 20.89 | 18.76% | $512.97 | $24.56 |
| Sep 2022 | 17.59 | -7.62% | $454.24 | $25.83 |
ELV Price vs fair value
ELV average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of ELV is above the 3, 5 and 10-year historical averages.
PE comparison
With a P/E of 17.58, ELV is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 23.77, Elevance Health's P/E is 26% lower.
ELV PE vs peers
ELV's PE ratio is higher than its peer stock PFG.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFG Principal Financial Group Inc | 14.88 | $22.73B |
| ELV Elevance Health Inc | 17.58 | $90.24B |
| OSCR Oscar Health Inc | N/A | $7.39B |
Frequently asked questions
What is Elevance Health's PE ratio?
The price to earnings ratio for ELV stock as of Jun 5, 2026, stands at 17.58.
What is the 3-year average PE ratio for Elevance Health (ELV)?
The 3-year average PE ratio for ELV stock is 16.39.
What is the 5-year average PE ratio for Elevance Health (ELV)?
The 5-year average PE ratio for ELV stock is 17.41.
What is the highest PE ratio for ELV?
The highest quarterly PE ratio in the last ten years has been 22.09 and it was in the Jun 2021 quarter.
How does the current PE ratio for ELV compare to its historical average?
The current price to earnings ratio of ELV is 7% higher than the 10-year historical average.
How is ELV's PE ratio calculated (Elevance Health PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 5, 2026), Elevance Health's stock price is $415.53. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $23.64. Therefore, Elevance Health's P/E ratio for today is 17.58. PE RATIO(17.58) = STOCK PRICE($415.53) / TTM EPS($23.64)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.